During the past decade, Zhongshan Hospital Xiamen University conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 3 clinical trials were completed, i.e. on average, 6.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhongshan Hospital Xiamen University" #1 sponsor was "Zhongshan Hospital Xiamen University" with 10 trials, followed by "Air Force Military Medical University, China" with 5 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Takeda" with 3 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhongshan Hospital Xiamen University" #1 collaborator was "Zhongshan Hospital Xiamen University" with 5 trials as a collaborator, "Nanfang Hospital of Southern Medical University" with 3 trials as a collaborator, "Chinese PLA General Hospital" with 2 trials as a collaborator, "Fujian Medical University Union Hospital" with 2 trials as a collaborator and "Huaihe Hospital of Henan University" with 2 trials as a collaborator. Other collaborators include 91 different institutions and companies that were collaborators in the rest 96 trials.

According to Clinical.Site data, the most researched conditions in "Zhongshan Hospital Xiamen University" are "Colonoscopy" (4 trials), "Crohn's Disease" (4 trials), "Gastric Cancer" (4 trials), "Bowel Preparation" (3 trials) and "Endoscopic Retrograde Cholangiopancreatography" (2 trials). Many other conditions were trialed in "Zhongshan Hospital Xiamen University" in a lesser frequency.

Most popular intervention types in "Zhongshan Hospital Xiamen University" are "Drug" (33 trials), "Other" (12 trials), "Device" (5 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apatinib Mesylate" (2 trials), "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (2 trials) and "Camrelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Zhongshan Hospital Xiamen University" are 55 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 22 active trials in "Zhongshan Hospital Xiamen University". 1 are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 17 completed trials in Zhongshan Hospital Xiamen University, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Zhongshan Hospital Xiamen University, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 13 trials that are defined as “Not Applicable".